Medical and Scientific: Giant leap in cancer battle

18 Jan 2021 - Medical and Scientific

Experts have hailed a “quantum leap” for women with ovarian cancer as a breakthrough treatment was given the go-ahead yesterday. The drug niraparib was approved for use by British regulators in the biggest improvement in 30 years for ovarian cancer treatment. Niraparib can halt the disease for about 12 months, putting off the need for further chemotherapy and allowing women to have the best quality of life possible. It will be available for women with advanced ovarian cancer from their first round of treatment, meaning about 3000 patients will have access to it every year.

The West Australian; 16/01/2021; Page 35